Lifecore Biomedical, Inc.
NasdaqGS:LFCR
Sector
Location
Market Cap
USD 284.30 M
Share Price
USD 7.60
Avg Daily Volume
189,501
Change (1 day)
5.26%
Change (1 year)
33.10%
Change (YTD)
2.29%
Lifecore Biomedical, Inc. Shareholders' Equity for the year ending May 25, 2025: USD 47.43 M
Lifecore Biomedical, Inc. Shareholders' Equity is USD 47.43 M for the year ending May 25, 2025, a -12.00% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
-
Lifecore Biomedical, Inc. Shareholders' Equity for the year ending May 26, 2024 was USD 53.90 M, a 53.62% change year over year.
-
Lifecore Biomedical, Inc. Shareholders' Equity for the year ending May 28, 2023 was USD 35.09 M, a -67.55% change year over year.
-
Lifecore Biomedical, Inc. Shareholders' Equity for the year ending May 29, 2022 was USD 108.14 M, a -46.67% change year over year.
-
Lifecore Biomedical, Inc. Shareholders' Equity for the year ending May 31, 2021 was USD 202.78 M, a -12.23% change year over year.
StockViz
Competitors
MERCK Kommanditgesellschaft auf Aktien
USD 131.46
MRK.DE
+3.21
2.50%
WuXi AppTec Co., Ltd.
USD 13.21
2359.HK
+0.11
0.81%
Bayer AG
USD 33.48
BAYN.DE
+0.83
2.54%
Teva Pharmaceutical Industries Limited
USD 18.33
TEVA.TA
+0.81
4.61%
Lupin Limited
USD 22.60
LUPIN.NS
+0.13
0.58%
Pharmaron Beijing Co., Ltd.
USD 2.77
3759.HK
+0.05
1.72%
Aurobindo Pharma Limited
USD 12.02
AUROPHARMA.NS
+0.10
0.86%
Asymchem Laboratories (Tianjin) Co., Ltd.
USD 14.86
002821.SZ
+0.09
0.59%
Zhejiang Huahai Pharmaceutical Co., Ltd.
USD 3.14
600521.SS
+0.09
2.92%
Siegfried Holding AG
USD 107.30
SFZN.SW
+2.57
2.45%
Hybio Pharmaceutical Co., Ltd.
USD 3.95
300199.SZ
-0.22
-5.23%
Syngene International Limited
USD 7.64
SYNGENE.NS
-0.01
-0.10%
Piramal Pharma Limited
USD 2.21
PPLPHARMA.NS
+0.01
0.32%
Yifan Pharmaceutical Co., Ltd.
USD 2.24
002019.SZ
+0.05
2.33%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd
USD 2.57
603456.SS
+0.00
0.11%
Key Data
| Date | Shareholders' Equity | Cash and Short-Term Investments | Receivables | Inventory |
|---|
Competitors
MERCK Kommanditgesellschaft auf Aktien
USD 131.46
MRK.DE
+3.21
2.50%
WuXi AppTec Co., Ltd.
USD 13.21
2359.HK
+0.11
0.81%
Bayer AG
USD 33.48
BAYN.DE
+0.83
2.54%
Teva Pharmaceutical Industries Limited
USD 18.33
TEVA.TA
+0.81
4.61%
Lupin Limited
USD 22.60
LUPIN.NS
+0.13
0.58%
Pharmaron Beijing Co., Ltd.
USD 2.77
3759.HK
+0.05
1.72%
Aurobindo Pharma Limited
USD 12.02
AUROPHARMA.NS
+0.10
0.86%
Asymchem Laboratories (Tianjin) Co., Ltd.
USD 14.86
002821.SZ
+0.09
0.59%
Zhejiang Huahai Pharmaceutical Co., Ltd.
USD 3.14
600521.SS
+0.09
2.92%
Siegfried Holding AG
USD 107.30
SFZN.SW
+2.57
2.45%
Hybio Pharmaceutical Co., Ltd.
USD 3.95
300199.SZ
-0.22
-5.23%
Syngene International Limited
USD 7.64
SYNGENE.NS
-0.01
-0.10%
Piramal Pharma Limited
USD 2.21
PPLPHARMA.NS
+0.01
0.32%
Yifan Pharmaceutical Co., Ltd.
USD 2.24
002019.SZ
+0.05
2.33%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd
USD 2.57
603456.SS
+0.00
0.11%